Vijaya Diagnostic Centre Limited has announced a final dividend of ₹2 per share for the fiscal year ended March 31, 2026. Alongside the financial results, the board approved the acquisition of MRI, EEG, and NCV services from its subsidiary for ₹4.20 crore. Furthermore, the company has granted 1,79,500 employee stock options and noted the upcoming departure of Independent Director Dr. D Nageshwar Reddy, effective May 25, 2026.
Financial Highlights and Dividend
Following the conclusion of the fiscal year ended March 31, 2026, the board has recommended a final dividend of ₹2 per equity share, representing a 200% payout on the face value of ₹1 per share. This proposal is subject to shareholder approval at the upcoming Annual General Meeting.
Strategic Business Acquisition
To streamline operations, the company is acquiring the MRI, EEG, and NCV services business from its wholly-owned subsidiary, Medinova Millennium MRI Services LLP. This move, valued at approximately ₹4.20 crore, is expected to create new growth opportunities and align with the company’s long-term strategic goals. The transaction is projected to be completed within three months.
Employee Incentive Program
The company has initiated a new grant of 1,79,500 employee stock options (ESOPs) under the 2018 Plan. These options are priced at ₹784 per share, determined based on the average closing price of the previous three months minus a 20% discount. The vesting schedule is designed to incentivize both long-term tenure and performance-based results across various departments.
Board and Leadership Changes
The company acknowledged the decision of Dr. D Nageshwar Reddy to step down as an Independent Director upon the completion of his current term on May 25, 2026. Dr. Reddy cited his pre-occupation and other professional commitments as the reasons for not seeking reappointment. Additionally, the company has reappointed M/s. Santhosh & Associates as the cost auditors for the 2026-27 financial year.
Source: BSE
